Bad News for Device Sponsors: Panel Meetings were Already Going the Way of the Homework Assignment, and COVID Might "Put the Nail in the Coffin"

Counsel Kristin Zielinski Duggan and associate Sandra Milena McCarthy co-authored an article published by the Food and Drug Law Institute.

In the article, Kristin and Sandra discuss the declining trend in U.S. Food and Drug Administration in-person panel meetings and review the disadvantages to companies of alternatives, such as increased reliance on panel homework assignments.

Read More: Bad News for Device Sponsors: Panel Meetings were Already Going the Way of the Homework Assignment, and COVID Might "Put the Nail in the Coffin"


Back To Listing
Loading data